NFKB1 and polycystic ovary syndrome: As a pro-inflammatory steroid hormone, HA induces SLCI in the ovaries by stimulating monocyte infiltration, enhancing ROS production, and activating the NF-κB pathway, which contributes to metabolic disorders in PCOS patients (141).